NEW YORK (GenomeWeb) – Medicinal Genomics and Courtagen have been awarded a Small Business and Innovation Research grant to develop technology to detect toxins from microbiological contamination of medical marijuana, the companies said today.

The Phase I award from the National Institute on Drug Abuse is for approximately $150,000 and will go toward developing immuno-PCR-based tests, Mike Catalano, senior director of marketing for Medicinal Genomics, said in an email.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.